- Home
- TCBS vs VNRX Comparison
TCBS vs VNRX Comparison
Compare TCBS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- VNRX
- Stock Information
- Founded
- TCBS 1934
- VNRX N/A
- Country
- TCBS United States
- VNRX United States
- Employees
- TCBS N/A
- VNRX N/A
- Industry
- TCBS Banks
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TCBS Finance
- VNRX Health Care
- Exchange
- TCBS Nasdaq
- VNRX Nasdaq
- Market Cap
- TCBS 48.8M
- VNRX 52.4M
- IPO Year
- TCBS N/A
- VNRX N/A
- Fundamental
- Price
- TCBS $16.21
- VNRX $0.75
- Analyst Decision
- TCBS
- VNRX Strong Buy
- Analyst Count
- TCBS 0
- VNRX 5
- Target Price
- TCBS N/A
- VNRX $3.88
- AVG Volume (30 Days)
- TCBS 3.8K
- VNRX 318.0K
- Earning Date
- TCBS 08-12-2025
- VNRX 08-13-2025
- Dividend Yield
- TCBS 1.00%
- VNRX N/A
- EPS Growth
- TCBS N/A
- VNRX N/A
- EPS
- TCBS 0.68
- VNRX N/A
- Revenue
- TCBS $14,488,000.00
- VNRX $1,308,361.00
- Revenue This Year
- TCBS N/A
- VNRX $563.72
- Revenue Next Year
- TCBS N/A
- VNRX $160.43
- P/E Ratio
- TCBS $23.59
- VNRX N/A
- Revenue Growth
- TCBS 54.08
- VNRX 64.16
- 52 Week Low
- TCBS $13.52
- VNRX $0.40
- 52 Week High
- TCBS $17.50
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- TCBS 58.70
- VNRX 56.08
- Support Level
- TCBS $15.90
- VNRX $0.71
- Resistance Level
- TCBS $16.15
- VNRX $0.92
- Average True Range (ATR)
- TCBS 0.09
- VNRX 0.11
- MACD
- TCBS -0.00
- VNRX -0.00
- Stochastic Oscillator
- TCBS 87.14
- VNRX 50.39
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.